Utah State University

DigitalCommons@USU
Undergraduate Honors Capstone Projects

Honors Program

5-2005

The Adverse Health Effects of Trans Fatty Acids, and Implications
for Public Policy
Jonathan D. Atkin
Utah State University

Follow this and additional works at: https://digitalcommons.usu.edu/honors
Part of the Dietetics and Clinical Nutrition Commons

Recommended Citation
Atkin, Jonathan D., "The Adverse Health Effects of Trans Fatty Acids, and Implications for Public Policy"
(2005). Undergraduate Honors Capstone Projects. 785.
https://digitalcommons.usu.edu/honors/785

This Thesis is brought to you for free and open access by
the Honors Program at DigitalCommons@USU. It has
been accepted for inclusion in Undergraduate Honors
Capstone Projects by an authorized administrator of
DigitalCommons@USU. For more information, please
contact digitalcommons@usu.edu.

-,

THE ADVERSE HEALTH EFFECTS OF TRANS FATTY ACIDS,
AND IMPLICATIONS FOR PUBLIC POLICY
By

Jonathan D. Atkin

Thesis submitted in partial fulfillment
of the requirements for the degree
of
DEPARTMENT HONORS

in
Nutrition and Food Sciences

Approved:

Department Honors Advisor

Thesis/Project Advisor

Alorem
B.5 chvtH1fveldf;
fY{s
/ RP

lla.cie,K-Wakh;
fl b

Director of Honors Program

UTAH STATE UNIVERSITY
Logan, UT

Spring 2005

Authors' Page
Date: April 13, 2005
Title: The adverse health effects of trans fatty acids, and implications for public policy .
Key Words: partial hydrogenation, trans fatty acids, saturated fatty acids, low-density
lipoprotein , high-density lipoprotein , coronary heart disease, ischemic heart disease
Abstract Word Count: 255
Text Word Count: 3,201
Author's Information: Jonathan D. Atkin , B.S. Nutrition and Food Sciences , emphasis
in dietetics (to be awarded May 7, 2005), Department of Nutrition and Food Sciences ,
Logan, UT 84322-8700, Phone (435) 797-2126 , Fax (435) 797-2379 .
Author ' s personal phone (801) 440-9404 , email jda @cc.usu .edu.

ABSTRACT

Subject: Trans fatty acids (TFAs) are produced either by the process of bacterial
hydrogenation in the stomachs of ruminant animals, or the commercial method called
industrial hydrogenation.

The latter began early in the 20 th century based on purported

health benefits and lowered costs. Alarming results from scientific studies in the early
1990' s began to raise questions about whether TF As should be regulated in our food
supply.

Findings/Statistics: Scientific research initially discovered that TF As raise the
LDL/HDL ratio, thereby increasing the risk of coronary heart disease (CHD) . Recent
large , prospective, population-based studies have indicated a 25% increased risk of
ischemic heart disease (IHD) from an increased TFA consumption equaling 2% of total
energy intake (or 2E%). Gram for gram , the risk ofIHD from TFAs is estimated to be
2.5 to 10 times greater than from saturated fat. More research is needed to support claims
th e TF As play harmful roles in poor fetal and infant growth , and in the development of
cancer , type 2 diabetes , and allergies. The effects of newly adopted TFA labeling
regulations on the steady , average U.S . consumption remains to be seen. Danish
regulation of TF As limits production, and has been associated with a lower national
average intake and IHD death rate.

Applications/Conclusions: Considering the indisputable evidence linking TFA intake to
IHD risk, the question must be posed whether the U.S. regulations requiring labeling of
TF A content are adequate . Special consideration is needed to determine the most
effective ways to reduce TF A content in foods as well as the average U.S. consumption.
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INTRODUCTION
TF As are primarily the product of a process called partial hydrogenation (1 ). This
includes heating vegetable oils in the presence of metal catalysts and hydrogen, resulting
in hydrogen being forced to bond with unsaturated carbons. Where cis unsaturated fatty
acids are normally in a bent shape with adjacent carbons on the same side of the double
bond, trans isomers have adjacent carbons on opposite sides of the double bond resulting
in a straight configuration.

This shape allows for the production of fats that are more

stable and stay solid at room temperature, such as margarines and shortening (1,2).
These manipulated qualities allow for easier storage and transportation (2).
TF As are also formed by bacterial hydrogenation in the rumen of cattle (1,2).
Therefore, these isomers are found in dairy and beef fat, although in lower levels
compared to partially hydrogenated fats. Less than 5% of ruminant fat is TF As, whereas
industrially hydrogenated fats contain up to 60% TF As (2).
There are many different kinds of TF As (2). Commercial hydrogenation
predominantly creates monounsaturated isomers, the most common being trans elaidic
acid (18: 1 f19-trans). Bacterial hydrogenation produces mainly trans vaccenic acid
( 18: lfi 11-trans ). However, isomers of linoleic acid, called conjugated linoleic acids
(e.g.18 :2 f19cis,11-trans ), are also found in ruminant fat.
th

The process of partial hydrogenation began in the early 20 century, and TF A
consumption increased with it until the 1960' s (1). Lower costs and purported health
benefits were supporting arguments for replacing animal fats with these processed
vegetable oils. As softer vegetable margarines increased in popularity, levels of TF As
also declined, and average per capita consumption of TFAs in the U.S. has remained at,
or just above, 2% of calories since the 1960's (1,3). The ever increasing consumption of
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baked products has maintained this average TF A intake despite many people switching to
softer vegetable spreads (1 ).
In the recent past, research has uncovered several reasons to be concerned with
consumption ofTFAs, the most compelling of which is their deleterious effects on lowdensity lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, and strong
association with risk of CHD (1,2).
TRANS FATTY ACIDS AND HEART DISEASE
In the early 1990 ' s, concern about the negative health implications of trans
isomers of unsaturated fatty acids increased (1,4). Controlled dietary intervention trials
clearly showed that they raised total cholesterol, although the effect was less than that of
saturated fat. However, further studies showed that focusing on total cholesterol was
masking the specific effects ( 1). Scientists discovered that while both saturated and trans
fats raise LDL similarly , TF As also lowered HDL. One particular study switched a diet
with 10% energy from oleic acid (the primary monounsaturated fat in diets) with
comparable amounts of trans fat (1). LDL cholesterol raised 14mg per deciliter , and
HDL decreased by 7mg per deciliter. When saturated fat replaced the oleic acid in the
diet, LDL levels rose in a similar fashion , but HDL cholesterol remained the same .
Researchers have discovered that the amount of fatty acids measured in blood
plasma , erythrocytes, and adipose tissue reflects intake during the previous weeks,
months, and full year, respectively (2). They have begun studying how these markers
relate to incidence of ischemic heart disease (IHD) . So far results have been inconsistent.
One particular American case-control study showed that plasma TF As were higher in
subjects with CHD compared to those without (5). However, studies that have linked
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adipose TF A content with IHD may be the most compelling. Two recent ones have
demonstrated this link with heart disease (2,5) .
The first, a Norwegian case-control study, demonstrated a significantly higher
amount of TF As in the adipose tissue of first-time myocardial infarction (MI) patients
compared to controls (2). When comparing the 20% of participants with the highest
adipose TF A content with the 20% with the lowest, the odds ratio of having a first-time
MI was nearly 3 times higher for the former group (adjusted for age and gender) (2) .
The second study was an Australian case-control study (5) . The project
encountered a rare opportunity half-way through the study period when Australian food
producers started making some of the most popular margarines TF A-free. Therefore, the
researchers were able to study changes that took place in adipose tissue over time with a
concurrent change in food supply . They also took data on TF A consumption.

Results

showed that adipose levels of trans 18: 1(n-11) from both animal and vegetable fats was a
significant independent predictor of first MI, high blood pressure, high total cholesterol,
and high triglyceride levels. It was also shown that MI cases had a 24% greater intake of
TFAs than controls . And finally, they concluded that about 15% of total TFA adipose
content disappears every year with a decreased consumption of margarines.
Four extensive population-based studies have shown perhaps the most clear
evidence that TFA intake negatively influences rates ofIHD (reviewed in 2). They are
the Health Professionals Follow-up Study, the Alpha-Tocopherol , Beta-Carotene Cancer
Prevention Study, the Nurse's Health Study, and the Zutphen Elderly Study. Each study
calculated "the relative risk of IHD associated with an increase in TF A intake
corresponding to [2E%]"(reviewed in 2). After correcting for certain confounding
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factors , the combined results showed a 25% increased risk associated with a 2E%
increase in TF A intake.
Other findings from these studies agree with the afore-mentioned greater affect of
trans fat compared to saturated fat on LDL/HDL ratio . Three out of the 4 studies
concluded that the relative risk of IHD was stronger with respect to TFAs compared to
saturated fat (2).
Ascherio et al. (1) compared the results of 6 randomized studies that looked at the
affects of isocaloric amounts of saturated fatty acids and industrial TFAs on LDL/HDL
ratio. It was summarized that an increased TF A consumption of 2E% increases the ratio
by 0.1. The same consumption of saturated fatty acids increased the ratio by a lesser
0.04 . These numbers account for a 5% and 2% increased risk of IHD, respectively ,
therefore showing the comparably greater risk of TF As. As a 1-unit increase in ratio
equates to about a 53% increased risk ofCHD, a similarly increased average TFA intake
(2E%) in the U.S . would theoretically account for a substantial number of deaths per year
(1,2).
When comparing the results showing increased risk of IHD based on raised
LDL/HDL ratio (5% increased risk with 2E% increased TFA intake) with that of the 4
large population-based studies (averaged, fully adjusted increased risk of 25% with the
same increase in TF A intake), it becomes apparent that 20% of the risk is not due to the
increased LDL/HDL ratio (2). The risk posed by saturated fat, on the other hand, is fully
predicted by its effect on the ratio. Referring back to the calculated 2% increased risk
(for IHD when saturated fat is replaced instead ofTFAs), the difference is at least a 10fold greater effect ofTFAs gram for gram (25% compared to 2%). Even the most
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conservative estimates give TFAs a 2.5 greater risk increment than saturated fatty acids
for IHD (2).
As eluded to previously, other adverse effects of TF As are presumably playing a
much greater role in the overall risk for IHD compared to causing the blood lipid ratio to
rise (1,2). It is theorized that approximately 80% of the risk could be due to the effect of
TFAs on lipoprotein (a) (Lp(a)), triglycerides, and/or endothelial function .
Lp(a) is a LDL particle linked to apoprotein (a) (6). Although not yet proven,
some believe it to be an independent risk factor for CHD and even more atherogenic than
LDL. Should it be found to be so, and ifit is clearly discovered that TFAs cause blood
levels to rise, the argument to eliminate TF As from the food supply would be that much
stronger. Studies that have tested the effect of TF As on Lp( a) levels have been
controversial (1,6) . Ascherio et al (1) reported 9 of 10 studies weighing in on the
affirmative with an average of 0.5mg per deciliter increase for every 2E% increase in
TF A intake. Other researchers have criticized these results stating that the levels of TF As
given were higher than typical U.S . intakes (6). Clevidence et al.(6) compared the effects
of a normal and high amount ofTFAs, and a 16.2E% saturated fat diet on Lp(a) levels
compared to a control diet. Their results did not indicate any adverse effects by the trans
diets on Lp(a) levels compared to the control diet. However, a subset of subjects with
already high Lp(a) levels did have an additional 5% rise in response to the high trans diet
compared to the moderate trans and control diets. Therefore, their conclusions denied any
adverse effects ofTFAs on Lp(a) levels, except for people who fit the description of this
non-typical subset.
A study conducted in 2001 raised interesting questions about the effect of TF As
on endothelial function (7) . Using a randomized cross -over design, subjects were
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provided a 9.2E% trans diet and a saturated fat, each lasting 4 weeks . Endothelial
function was assessed by taking flow-mediated vasodilation (FMD) measurements of the
brachia! artery , a non-invasive measurement that correlates well with CHD risk factors
and markers. The results showed a 20% reduction in HDL on the trans diet compared to
the saturated diet. Concomitantly, subjects also experienced a 30% decrease in FMD.
The results were consistent independent of the order in which the diets were given.
Whether the decrease in FMD was attributable to the lowering in HDL could not
be determined (7) . However, several hypotheses were offered. First, endothelial function
is known to respond positively to higher HDL concentrations. The antioxidant properties
ofHDL could explain this. With more HDL , LDL may be more effectively kept from
being oxidized, thereby decreasing the amount of function-compromising damage
incurred by the endothelium. Second, other factors such as lowered LDL concentrations
and reduced homocysteine have been shown to improve FMD. Therefore, changes in
HDL may also cause variations in FMD . The researchers concluded with the statement
that more research was needed to verify whether lowered HDL with high intakes of trans
fats does indeed impair endothelial function, thereby increasing the risk of CHD .
An alternate hypothesis for the negative effect of TF As on IHD is derived from
what is known about the beneficial effects of n-3 fatty acids on cardiac rhythm (2). An
intake of 1g per day is associated with a decreased risk of cardiac arrhthmias . Supportive
evidence comes from studies looking at cultured heart myocytes that have incorporated
these polyunsaturated fatty acids into their structures , and from other cultured heart
myocytes from primary cardiac arrest patients that had more TFAs compared to non-MI
controls .
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There is conflicting data regarding whether ruminant TFAs have equal or
differing effects on IHD risk compared to their industrial counterparts (4). ill the
Zutphen Elderly Study, the 2 trans types were investigated based on this unanswered
question. The results indicated similar risk of CHD from all TF A sources . The Nurse's
Health Study showed a slight inverse relative risk between naturally occurring TFAs and
CHD (reviewed in 4). The other 2 large prospective studies failed to produce any clear
results differentiating risk. Considering all these together, the Zutphen Elderly Study
research team concluded that industrial and ruminant TFAs pose similar health risks.
OTHER POSSIBLE HEALTH IMPLICATIONS
Long-chain polyunsaturated fatty acids (LCPUF As) such as arachadonic acid
(AA) and docosahexanoic acid (DHA) play vital roles in proper fetal and infant growth,
including the development of the central nervous system (8). AA plays roles in cellsignaling, cell division, is incorporated in cell membrane phospholipids, and is an
eicosanoid precursor. DHA is involved in both visual and nervous system function.
Recent research has shown that TF As from maternal blood are transferred to the fetus (2).
Once there, they may inhibit growth and development by preventing the desaturation of
linoleic (n-6) and alpha-linolenic acids (n-3) into AA and DHA (8). ill addition, infant n3 and n-6 fatty acid status at birth has been found a determinant of DHA and AA status
later in life. Therefore , maternal intake of TF As may negatively influence fetal, infant,
and older infant growth and development.
Desci et al. (9) studied cord blood concentrations of TFAs, AA, and DHA in fullterm infants. Their results showed significant inverse relationships between the sum of
TFAs and the two essential fatty acids in phospholipids. The research of Elias and funis
(8) showed similar findings. However, their study went further by studying the effects of
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industrial and certain ruminant TFAs called conjugated linoleic acids (CLAs). CLAs
were found to be inversely related to birth weight, length, and length of gestation. This is
in opposition to the known association with n-3 fatty acid intake and prolonged gestation
(2). They concluded that "for every 1% increase in infant plasma triacylglycerol CLAs,
length of gestation would decrease by only 0.5 days, and birth length would decrease by
1 cm" (8). They also predicted that birth weight would decrease by 31 0g for every 1%
increase in cholesteryl ester CLAs. The researchers called for more studies to further
investigate the biological activity of CLAs in maternal-fetal relationships.
Studies seeking to find a link between TF As and cancer have had equivocal
findings (2). Some have uncovered positive associations between TF As in adipose tissue
and the incidence of colon and breast cancers, but not prostate cancer. Others have found
no positive associations with either colon or breast cancer, but have discovered certain
population subsets having increased risk with increased TF A intake. More research is
warranted in this realm .
One extensive epidemiological study showed higher rates of asthma among
populations with higher intakes of TFAs (9). Although these results may justify further
investigation, the association is rather weak with many possible confounding factors to
consider (2).
Follow-up analysis of the Nurses Health Study showed a positive association
between TF A intake and risk for type-2 diabetes (reviewed in 2). However, 2 other
comparable studies showed no such association. Nevertheless, other studies have
indicated that TFAs incorporated into skeletal muscle may contribute to insulin
resistance .
CURRENT INT AKES
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A study printed in the Journal of the American Dietetic Association in 1999
estimated the average intake ofTFAs in the U.S. (3). The data used came from the
Continuing Survey of Food Intakes by Individuals (CSFII) for 1989-1991. A newly
updated 1995 USDA database containing TF A composition of foods was used to estimate
the current intakes. The average estimated amount of daily TFAs consumed was 5.3g.
This represented 2.6% of total daily energy intake, and 7.4% of the average total fat
consumed. In comparison, saturated fat intake was 12.5% of total daily energy intake,
and about 35.2% of total fat consumed. Naturally occurring TFAs accounted for an
estimated 20-25% of total intake. This equates to about 1 to 1.3g per day, a range which
other researchers had accurately estimated previously.
From the 1999 food composition study, it appears that the use of hydrogenated
vegetable oils in margarines is slowly decreasing, while softer, lower TF A versions are
becoming more popular (3). Ascherio et al (1) reports that the increasing consumption of
baked and fast fried foods is the factor which maintains the current average of ingested
TFAs in the U.S .
GOVERNMENTAL REGULATIONS

It became clear by the early 1990's that TFA intake was associated with specific
detrimental health effects (1). In 1995, an industry-sponsored review concluded that
there was not enough evidence to warrant any governmental mandates at that time.
Further research was done, and by the end of 1999 the FDA officially proposed to amend
its regulations on nutrition labeling as far as trans fats were concerned (10). The proposal
included 3 main changes. First, if a product contained TF As, the declaration of saturated
fat would have a symbol next to it referring the reader to a footnote which would disclose
the amount of trans fat in grams. Second, products containing TF As would be treated as

those containing saturated fats regarding limits on any content or health claims. And
third, the content claim of "trans fat free" was proposed .
On July 11, 2003, the FDA officially amended its nutrition labeling regulations .
This required TF A content of conventional foods and dietary supplements to be listed on
a separate line directly under saturated fat (11). The requirements make no distinction
between industrially-produced and ruminant TF As (2). All concerned are to come into
compliance with these regulations by January 1, 2006.
ALTERNATIVE APPROACHES TO LIMITING TRANS FATS
Though the U.S. has come forth and decreed enforced regulation of TF A content,
it remains to be seen whether consumption will decrease. The food industry and
government of Denmark have taken more active roles in TFA regulation with a marked
decline in intake (2) .
In 1976, Denmark's intake ofTFAs was comparable to the U.S . at 6g per day (2).
Reports of the adverse effects of trans fats on serum lipoproteins eventually led to
margarine manufactures to decrease their use of TF As (4 ). As margarines once included
approximately 50% trans fat, today's versions contain an average of 1-2% (2). This
decreased TF A content in the food supply has been associated with a substantial decline
in average consumption per capita. From 1991 to 1996 the mean intake dropped from 5.2
to 2.6g per day, respectively. Furthermore, in March of 2003 the Danish government
decided to ban the sale of fats and oils containing more than 2% content of industriallyproduced TFAs. This became effective January 1, 2004.
Remarkably, death rates from IHD in Denmark declined >50% from 1976 to 1996
with a decrease in average industrial TF A consumption from 6g per day to less than 1 (2).
Although other factors have likely played a significant role, one must consider how much
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of an effect the decreased trans fat consumption actually did make. Of note, the research
team in the Zutphen Elderly Study estimated that a 2.4E% decrease in trans fat intake
could equate to 23% fewer CHD deaths in the U.S. (4).
CONCLUSIONS/APPLICATIONS
At this point in time there is clear evidence that TF As pose a considerable risk to
heart health, and may play deleterious roles in the proper growth of infants, and the
development of cancer, diabetes, and allergies (2,8,9) . At the same time, there has been
no evidence that removing them from our food supply would cause any harmful health
effects (1,2). Therefore, the question must be posed whether the current federal
regulations requiring food manufacturers to indicate TF A amounts on labels are adequate.
Time will tell if the current mandates will result in decreased intakes. If not, the U.S.
government should consider following Denmark's example and take a more active role in
limiting production of industrial TF As . Policy-makers must seriously consider the ever
increasing evidence that a high intake of TF As is directly related to the CHD death rate
(4).
The industrial use of partially hydrogenated oils is mainly for marginal economic
benefits (2). With the unmistakable data supporting their serious effects on heart health,
efforts to provide alternatives or lesser trans versions must be made . Although producing
lower TF A margarines is relatively easy, replacing highly hydrogenated fats with lesser
trans versions in baked goods and fast fried foods may prove more difficult (1). As a
large proportion of TF As in the U.S. diet come from these latter sources, special
consideration is needed to determine the most effective ways to reduce TF As in these
foods .
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